Regency Centers Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell

42

REG
Regency Centers

Last Price:

71.61

Seasonality Move:

0.89%

Sell

19

APLS
Apellis Pharmaceuticals

Last Price:

32.49

Seasonality Move:

18.8%

Sell

42

Regency Centers (REG) is a Sell

Is Regency Centers a Buy, Sell or Hold?

The current Regency Centers [REG] share price is $71.58. The Score for REG is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
REG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

19

Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

REG Stock Price Chart

What is Regency Centers's stock price today?

The Regency Centers share price today is $71.58
The current trend is moderately bearish and REG is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

The Apellis Pharmaceuticals share price today is $32.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

REG Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.92	Buy
Relative Strength Index (14 RSI):	46.56	Sell
Chaikin Money Flow:	-877461	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(70.94 - 74.02)	Sell
Bollinger Bands (100):	(60.19 - 70.57)	Buy

APLS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.84	Sell
Relative Strength Index (14 RSI):	33.6	Sell
Chaikin Money Flow:	-1084788	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(36.37 - 40.01)	Sell
Bollinger Bands (100):	(36.55 - 42.35)	Sell

REG Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	73.63	Sell
20-day SMA:	72.99	Sell
50-day SMA:	70.01	Buy
200-day SMA:	63.69	Buy
8-day EMA:	73.07	Sell
20-day EMA:	72.68	Sell
50-day EMA:	70.11	Buy
200-day EMA:	64.82	Buy

APLS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	36.19	Sell
20-day SMA:	38.04	Sell
50-day SMA:	37.88	Sell
200-day SMA:	50	Sell
8-day EMA:	35.96	Sell
20-day EMA:	37.21	Sell
50-day EMA:	38.25	Sell
200-day EMA:	45.7	Sell

Regency Centers Earnings Growth & REG Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.13 per share, and an increase next year of $0.12 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Regency Centers Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18	Sep 19	Sep 20
	Sep
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):